APO Research
Talk to an analyst

APO RESEARCH · REPORT

Valsartan Drug

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Valsartan Drug Industry Growth and Trends Forecast to 2032

20 December 2025110 pages

Choose your research edition.

Industry ResearchValsartan Drug Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal Valsartan Drug Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Valsartan Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Valsartan Drug Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Valsartan Drug Market Analysis and Forecast 2026-2032201 pages · $4,950 USD

Market perspective

The global Valsartan Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Valsartan Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Valsartan Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Valsartan Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Valsartan Drug include Zhejiang Huahai Pharmaceutical, Teva, Sun Pharmaceutical, Novartis, Mylan, Huaren Pharmaceutical, Unichem Laboratories, Torrent Pharmaceuticals and Square Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Valsartan Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Valsartan Drug market size, estimates, and forecasts are presented in terms of sales volume (W Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Valsartan Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Valsartan Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Valsartan Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Valsartan Drug Market by Company

Zhejiang Huahai Pharmaceutical

Teva

Sun Pharmaceutical

Novartis

Mylan

Huaren Pharmaceutical

Unichem Laboratories

Torrent Pharmaceuticals

Square Pharmaceuticals

Macleods Pharmaceuticals

Lupin

Jubilant Pharma

HETERO

Aurobindo Pharma

Amneal Pharmaceuticals

Alembic Pharmaceuticals

Valsartan Drug Segment by Type

40 mg Tablets

80 mg Tablets

160 mg Tablets

320 mg Tablets

Valsartan Drug Segment by Application

Heart Failure

Heart Attack

Hypertension

Valsartan Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Valsartan Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Valsartan Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Valsartan Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Valsartan Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Valsartan Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 40 mg Tablets Table 2. Major Company of 80 mg Tablets Table 3. Major Company of 160 mg Tablets Table 4. Major Company of 320 mg Tablets Table 5. Global Valsartan Drug Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Valsartan Drug Sales by Type (2021-2026) & (W Units) Table 7. Global Valsartan Drug Sales Market Share in Volume by Type (2021-2026) Table 8. Global Valsartan Drug Sales by Type (2021-2026) & (US$ Million) Table 9. Global Valsartan Drug Sales Market Share in Value by Type (2021-2026) Table 10. Global Valsartan Drug Price by Type (2021-2026) & (US$/Unit) Table 11. Global Valsartan Drug Sales by Type (2027-2032) & (W Units) Table 12. Global Valsartan Drug Sales Market Share in Volume by Type (2027-2032) Table 13. Global Valsartan Drug Sales by Type (2027-2032) & (US$ Million) Table 14. Global Valsartan Drug Sales Market Share in Value by Type (2027-2032) Table 15. Global Valsartan Drug Price by Type (2027-2032) & (US$/Unit) Table 16. North America Valsartan Drug Sales by Type (2021-2026) & (W Units) Table 17. North America Valsartan Drug Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Valsartan Drug Sales by Type (2021-2026) & (W Units) Table 19. Europe Valsartan Drug Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Valsartan Drug Sales by Type (2021-2026) & (W Units) Table 21. Asia-Pacific Valsartan Drug Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Valsartan Drug Sales by Type (2021-2026) & (W Units) Table 23. Latin America Valsartan Drug Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Valsartan Drug Sales by Type (2021-2026) & (W Units) Table 25. Middle East and Africa Valsartan Drug Sales by Type (2021-2026) & (US$ Million) Table 26. Valsartan Drug Industry Trends Table 27. Valsartan Drug Industry Drivers Table 28. Valsartan Drug Industry Opportunities and Challenges Table 29. Valsartan Drug Industry Restraints Table 30. Global Valsartan Drug Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Valsartan Drug Revenue Market Share by Company (2021-2026) Table 32. Global Valsartan Drug Sales by Company (2021-2026) & (W Units) Table 33. Global Valsartan Drug Sales Share by Company (2021-2026) Table 34. Global Valsartan Drug Market Price by Company (2021-2026) & (US$/Unit) Table 35. Global Valsartan Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Valsartan Drug Major Company Production Sites and Headquarters Table 37. Global Valsartan Drug Company, Product Type & Application Table 38. Global Valsartan Drug Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Valsartan Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Valsartan Drug Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Valsartan Drug Sales by Region (2021-2026) & (W Units) Table 43. Global Valsartan Drug Sales Market Share in Volume by Region (2021-2026) Table 44. Global Valsartan Drug Sales by Region (2021-2026) & (US$ Million) Table 45. Global Valsartan Drug Sales Market Share in Value by Region (2021-2026) Table 46. Global Valsartan Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 47. Global Valsartan Drug Sales by Region (2027-2032) & (W Units) Table 48. Global Valsartan Drug Sales Market Share in Volume by Region (2027-2032) Table 49. Global Valsartan Drug Sales by Region (2027-2032) & (US$ Million) Table 50. Global Valsartan Drug Sales Market Share in Value by Region (2027-2032) Table 51. Global Valsartan Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 52. Global Valsartan Drug Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Valsartan Drug Sales by Application (2021-2026) & (W Units) Table 54. Global Valsartan Drug Sales Market Share in Volume by Application (2021-2026) Table 55. Global Valsartan Drug Sales by Application (2021-2026) & (US$ Million) Table 56. Global Valsartan Drug Sales Market Share in Value by Application (2021-2026) Table 57. Global Valsartan Drug Price by Application (2021-2026) & (US$/Unit) Table 58. Global Valsartan Drug Sales by Application (2027-2032) & (W Units) Table 59. Global Valsartan Drug Sales Market Share in Volume by Application (2027-2032) Table 60. Global Valsartan Drug Sales by Application (2027-2032) & (US$ Million) Table 61. Global Valsartan Drug Sales Market Share in Value by Application (2027-2032) Table 62. Global Valsartan Drug Price by Application (2027-2032) & (US$/Unit) Table 63. North America Valsartan Drug Sales by Application (2021-2026) & (W Units) Table 64. North America Valsartan Drug Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Valsartan Drug Sales by Application (2021-2026) & (W Units) Table 66. Europe Valsartan Drug Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Valsartan Drug Sales by Application (2021-2026) & (W Units) Table 68. Asia-Pacific Valsartan Drug Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Valsartan Drug Sales by Application (2021-2026) & (W Units) Table 70. Latin America Valsartan Drug Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Valsartan Drug Sales by Application (2021-2026) & (W Units) Table 72. Middle East and Africa Valsartan Drug Sales by Application (2021-2026) & (US$ Million) Table 73. Zhejiang Huahai Pharmaceutical Company Information Table 74. Zhejiang Huahai Pharmaceutical Business Overview Table 75. Zhejiang Huahai Pharmaceutical Valsartan Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Zhejiang Huahai Pharmaceutical Valsartan Drug Product Portfolio Table 77. Zhejiang Huahai Pharmaceutical Recent Development Table 78. Teva Company Information Table 79. Teva Business Overview Table 80. Teva Valsartan Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Teva Valsartan Drug Product Portfolio Table 82. Teva Recent Development Table 83. Sun Pharmaceutical Company Information Table 84. Sun Pharmaceutical Business Overview Table 85. Sun Pharmaceutical Valsartan Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Sun Pharmaceutical Valsartan Drug Product Portfolio Table 87. Sun Pharmaceutical Recent Development Table 88. Novartis Company Information Table 89. Novartis Business Overview Table 90. Novartis Valsartan Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Novartis Valsartan Drug Product Portfolio Table 92. Novartis Recent Development Table 93. Mylan Company Information Table 94. Mylan Business Overview Table 95. Mylan Valsartan Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Mylan Valsartan Drug Product Portfolio Table 97. Mylan Recent Development Table 98. Huaren Pharmaceutical Company Information Table 99. Huaren Pharmaceutical Business Overview Table 100. Huaren Pharmaceutical Valsartan Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Huaren Pharmaceutical Valsartan Drug Product Portfolio Table 102. Huaren Pharmaceutical Recent Development Table 103. Unichem Laboratories Company Information Table 104. Unichem Laboratories Business Overview Table 105. Unichem Laboratories Valsartan Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Unichem Laboratories Valsartan Drug Product Portfolio Table 107. Unichem Laboratories Recent Development Table 108. Torrent Pharmaceuticals Company Information Table 109. Torrent Pharmaceuticals Business Overview Table 110. Torrent Pharmaceuticals Valsartan Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Torrent Pharmaceuticals Valsartan Drug Product Portfolio Table 112. Torrent Pharmaceuticals Recent Development Table 113. Square Pharmaceuticals Company Information Table 114. Square Pharmaceuticals Business Overview Table 115. Square Pharmaceuticals Valsartan Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Square Pharmaceuticals Valsartan Drug Product Portfolio Table 117. Square Pharmaceuticals Recent Development Table 118. Macleods Pharmaceuticals Company Information Table 119. Macleods Pharmaceuticals Business Overview Table 120. Macleods Pharmaceuticals Valsartan Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Macleods Pharmaceuticals Valsartan Drug Product Portfolio Table 122. Macleods Pharmaceuticals Recent Development Table 123. Lupin Company Information Table 124. Lupin Business Overview Table 125. Lupin Valsartan Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 126. Lupin Valsartan Drug Product Portfolio Table 127. Lupin Recent Development Table 128. Jubilant Pharma Company Information Table 129. Jubilant Pharma Business Overview Table 130. Jubilant Pharma Valsartan Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 131. Jubilant Pharma Valsartan Drug Product Portfolio Table 132. Jubilant Pharma Recent Development Table 133. HETERO Company Information Table 134. HETERO Business Overview Table 135. HETERO Valsartan Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 136. HETERO Valsartan Drug Product Portfolio Table 137. HETERO Recent Development Table 138. Aurobindo Pharma Company Information Table 139. Aurobindo Pharma Business Overview Table 140. Aurobindo Pharma Valsartan Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 141. Aurobindo Pharma Valsartan Drug Product Portfolio Table 142. Aurobindo Pharma Recent Development Table 143. Amneal Pharmaceuticals Company Information Table 144. Amneal Pharmaceuticals Business Overview Table 145. Amneal Pharmaceuticals Valsartan Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 146. Amneal Pharmaceuticals Valsartan Drug Product Portfolio Table 147. Amneal Pharmaceuticals Recent Development Table 148. Alembic Pharmaceuticals Company Information Table 149. Alembic Pharmaceuticals Business Overview Table 150. Alembic Pharmaceuticals Valsartan Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 151. Alembic Pharmaceuticals Valsartan Drug Product Portfolio Table 152. Alembic Pharmaceuticals Recent Development Table 153. North America Valsartan Drug Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 154. North America Valsartan Drug Sales by Country (2021-2026) & (W Units) Table 155. North America Valsartan Drug Sales Market Share by Country (2021-2026) Table 156. North America Valsartan Drug Sales Forecast by Country (2027-2032) & (W Units) Table 157. North America Valsartan Drug Sales Market Share Forecast by Country (2027-2032) Table 158. North America Valsartan Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. North America Valsartan Drug Market Size by Country (2021-2026) & (US$ Million) Table 160. North America Valsartan Drug Market Share by Country (2021-2026) Table 161. North America Valsartan Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. North America Valsartan Drug Market Share Forecast by Country (2027-2032) Table 163. Europe Valsartan Drug Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 164. Europe Valsartan Drug Sales by Country (2021-2026) & (W Units) Table 165. Europe Valsartan Drug Sales Market Share by Country (2021-2026) Table 166. Europe Valsartan Drug Sales Forecast by Country (2027-2032) & (W Units) Table 167. Europe Valsartan Drug Sales Market Share Forecast by Country (2027-2032) Table 168. Europe Valsartan Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 169. Europe Valsartan Drug Market Size by Country (2021-2026) & (US$ Million) Table 170. Europe Valsartan Drug Market Share by Country (2021-2026) Table 171. Europe Valsartan Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 172. Europe Valsartan Drug Market Share Forecast by Country (2027-2032) Table 173. Asia-Pacific Valsartan Drug Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 174. Asia-Pacific Valsartan Drug Sales by Country (2021-2026) & (W Units) Table 175. Asia-Pacific Valsartan Drug Sales Market Share by Country (2021-2026) Table 176. Asia-Pacific Valsartan Drug Sales Forecast by Country (2027-2032) & (W Units) Table 177. Asia-Pacific Valsartan Drug Sales Market Share Forecast by Country (2027-2032) Table 178. Asia-Pacific Valsartan Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 179. Asia-Pacific Valsartan Drug Market Size by Country (2021-2026) & (US$ Million) Table 180. Asia-Pacific Valsartan Drug Market Share by Country (2021-2026) Table 181. Asia-Pacific Valsartan Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 182. Asia-Pacific Valsartan Drug Market Share Forecast by Country (2027-2032) Table 183. Latin America Valsartan Drug Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 184. Latin America Valsartan Drug Sales by Country (2021-2026) & (W Units) Table 185. Latin America Valsartan Drug Sales Market Share by Country (2021-2026) Table 186. Latin America Valsartan Drug Sales Forecast by Country (2027-2032) & (W Units) Table 187. Latin America Valsartan Drug Sales Market Share Forecast by Country (2027-2032) Table 188. Latin America Valsartan Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 189. Latin America Valsartan Drug Market Size by Country (2021-2026) & (US$ Million) Table 190. Latin America Valsartan Drug Market Share by Country (2021-2026) Table 191. Latin America Valsartan Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 192. Latin America Valsartan Drug Market Share Forecast by Country (2027-2032) Table 193. Middle East and Africa Valsartan Drug Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 194. Middle East and Africa Valsartan Drug Sales by Country (2021-2026) & (W Units) Table 195. Middle East and Africa Valsartan Drug Sales Market Share by Country (2021-2026) Table 196. Middle East and Africa Valsartan Drug Sales Forecast by Country (2027-2032) & (W Units) Table 197. Middle East and Africa Valsartan Drug Sales Market Share Forecast by Country (2027-2032) Table 198. Middle East and Africa Valsartan Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 199. Middle East and Africa Valsartan Drug Market Size by Country (2021-2026) & (US$ Million) Table 200. Middle East and Africa Valsartan Drug Market Share by Country (2021-2026) Table 201. Middle East and Africa Valsartan Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 202. Middle East and Africa Valsartan Drug Market Share Forecast by Country (2027-2032) Table 203. Key Raw Materials Table 204. Raw Materials Key Suppliers Table 205. Valsartan Drug Distributors List Table 206. Valsartan Drug Customers List Table 207. Research Programs/Design for This Report Table 208. Authors List of This Report Table 209. Secondary Sources Table 210. Primary Sources List of Figures Figure 1. Valsartan Drug Image Figure 2. Global Valsartan Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Valsartan Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Valsartan Drug Sales (2021-2032) & (W Units) Figure 5. 40 mg Tablets Image Figure 6. Global 40 mg Tablets Sales YoY Growth (2021-2032) & (W Units) Figure 7. 80 mg Tablets Image Figure 8. Global 80 mg Tablets Sales YoY Growth (2021-2032) & (W Units) Figure 9. 160 mg Tablets Image Figure 10. Global 160 mg Tablets Sales YoY Growth (2021-2032) & (W Units) Figure 11. 320 mg Tablets Image Figure 12. Global 320 mg Tablets Sales YoY Growth (2021-2032) & (W Units) Figure 13. Global Valsartan Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Valsartan Drug Market Share by Type 2025 VS 2032 Figure 15. North America Valsartan Drug Sales Market Share in Volume by Type in 2025 Figure 16. North America Valsartan Drug Sales Market Share in Value by Type in 2025 Figure 17. Europe Valsartan Drug Sales Market Share in Volume by Type in 2025 Figure 18. Europe Valsartan Drug Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Valsartan Drug Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Valsartan Drug Sales Market Share in Value by Type in 2025 Figure 21. Latin America Valsartan Drug Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Valsartan Drug Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Valsartan Drug Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Valsartan Drug Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Valsartan Drug Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Heart Failure Image Figure 28. Global Heart Failure Sales YoY Growth (2021-2032) & (W Units) Figure 29. Heart Attack Image Figure 30. Global Heart Attack Sales YoY Growth (2021-2032) & (W Units) Figure 31. Hypertension Image Figure 32. Global Hypertension Sales YoY Growth (2021-2032) & (W Units) Figure 33. Global Valsartan Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Valsartan Drug Market Share by Application 2025 VS 2032 Figure 35. North America Valsartan Drug Sales Market Share in Volume by Application in 2025 Figure 36. North America Valsartan Drug Sales Market Share in Value by Application in 2025 Figure 37. Europe Valsartan Drug Sales Market Share in Volume by Application in 2025 Figure 38. Europe Valsartan Drug Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Valsartan Drug Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Valsartan Drug Sales Market Share in Value by Application in 2025 Figure 41. Latin America Valsartan Drug Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Valsartan Drug Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Valsartan Drug Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Valsartan Drug Sales Market Share in Value by Application in 2025 Figure 45. North America Valsartan Drug Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 46. North America Valsartan Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Valsartan Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Valsartan Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Valsartan Drug Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 50. Europe Valsartan Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Valsartan Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Valsartan Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Valsartan Drug Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 54. Asia-Pacific Valsartan Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Valsartan Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Valsartan Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Valsartan Drug Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 58. Latin America Valsartan Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Valsartan Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Valsartan Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Valsartan Drug Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 62. Middle East and Africa Valsartan Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Valsartan Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Valsartan Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Valsartan Drug Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Valsartan Drug Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • 40 mg Tablets
  • 80 mg Tablets
  • 160 mg Tablets
  • 320 mg Tablets
Applications
  • Heart Failure
  • Heart Attack
  • Hypertension
Companies covered
  • Zhejiang Huahai Pharmaceutical
  • Teva
  • Sun Pharmaceutical
  • Novartis
  • Mylan
  • Huaren Pharmaceutical
  • Unichem Laboratories
  • Torrent Pharmaceuticals
  • Square Pharmaceuticals
  • Macleods Pharmaceuticals
  • Lupin
  • Jubilant Pharma
  • HETERO
  • Aurobindo Pharma
  • Amneal Pharmaceuticals
  • Alembic Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Valsartan Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Valsartan Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Valsartan Drug Market by Type
  6. 1.3.1 40 mg Tablets
  7. 1.3.2 80 mg Tablets
  8. 1.3.3 160 mg Tablets
  9. 1.3.4 320 mg Tablets
  10. 1.4 Global Valsartan Drug Market Size by Type
  11. 1.4.1 Global Valsartan Drug Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Valsartan Drug Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Valsartan Drug Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Valsartan Drug Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Valsartan Drug Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Valsartan Drug Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Valsartan Drug Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Valsartan Drug Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Valsartan Drug Industry Trends
  2. 2.2 Valsartan Drug Industry Drivers
  3. 2.3 Valsartan Drug Industry Opportunities and Challenges
  4. 2.4 Valsartan Drug Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Valsartan Drug Revenue (2021-2026)
  2. 3.2 Global Top Players by Valsartan Drug Sales (2021-2026)
  3. 3.3 Global Top Players by Valsartan Drug Price (2021-2026)
  4. 3.4 Global Valsartan Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Valsartan Drug Major Company Production Sites & Headquarters
  6. 3.6 Global Valsartan Drug Company, Product Type & Application
  7. 3.7 Global Valsartan Drug Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Valsartan Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Valsartan Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Valsartan Drug Tier 1, Tier 2, and Tier 3
4 Valsartan Drug Regional Status and Outlook
  1. 4.1 Global Valsartan Drug Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Valsartan Drug Historic Market Size by Region
  3. 4.2.1 Global Valsartan Drug Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Valsartan Drug Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Valsartan Drug Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Valsartan Drug Forecasted Market Size by Region
  7. 4.3.1 Global Valsartan Drug Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Valsartan Drug Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Valsartan Drug Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Valsartan Drug by Application
  1. 5.1 Valsartan Drug Market by Application
  2. 5.1.1 Heart Failure
  3. 5.1.2 Heart Attack
  4. 5.1.3 Hypertension
  5. 5.2 Global Valsartan Drug Market Size by Application
  6. 5.2.1 Global Valsartan Drug Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Valsartan Drug Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Valsartan Drug Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Valsartan Drug Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Valsartan Drug Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Valsartan Drug Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Valsartan Drug Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Valsartan Drug Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Zhejiang Huahai Pharmaceutical
  2. 6.1.1 Zhejiang Huahai Pharmaceutical Company Information
  3. 6.1.2 Zhejiang Huahai Pharmaceutical Business Overview
  4. 6.1.3 Zhejiang Huahai Pharmaceutical Valsartan Drug Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Zhejiang Huahai Pharmaceutical Valsartan Drug Product Portfolio
  6. 6.1.5 Zhejiang Huahai Pharmaceutical Recent Developments
  7. 6.2 Teva
  8. 6.2.1 Teva Company Information
  9. 6.2.2 Teva Business Overview
  10. 6.2.3 Teva Valsartan Drug Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Teva Valsartan Drug Product Portfolio
  12. 6.2.5 Teva Recent Developments
  13. 6.3 Sun Pharmaceutical
  14. 6.3.1 Sun Pharmaceutical Company Information
  15. 6.3.2 Sun Pharmaceutical Business Overview
  16. 6.3.3 Sun Pharmaceutical Valsartan Drug Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Sun Pharmaceutical Valsartan Drug Product Portfolio
  18. 6.3.5 Sun Pharmaceutical Recent Developments
  19. 6.4 Novartis
  20. 6.4.1 Novartis Company Information
  21. 6.4.2 Novartis Business Overview
  22. 6.4.3 Novartis Valsartan Drug Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Novartis Valsartan Drug Product Portfolio
  24. 6.4.5 Novartis Recent Developments
  25. 6.5 Mylan
  26. 6.5.1 Mylan Company Information
  27. 6.5.2 Mylan Business Overview
  28. 6.5.3 Mylan Valsartan Drug Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Mylan Valsartan Drug Product Portfolio
  30. 6.5.5 Mylan Recent Developments
  31. 6.6 Huaren Pharmaceutical
  32. 6.6.1 Huaren Pharmaceutical Company Information
  33. 6.6.2 Huaren Pharmaceutical Business Overview
  34. 6.6.3 Huaren Pharmaceutical Valsartan Drug Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Huaren Pharmaceutical Valsartan Drug Product Portfolio
  36. 6.6.5 Huaren Pharmaceutical Recent Developments
  37. 6.7 Unichem Laboratories
  38. 6.7.1 Unichem Laboratories Company Information
  39. 6.7.2 Unichem Laboratories Business Overview
  40. 6.7.3 Unichem Laboratories Valsartan Drug Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Unichem Laboratories Valsartan Drug Product Portfolio
  42. 6.7.5 Unichem Laboratories Recent Developments
  43. 6.8 Torrent Pharmaceuticals
  44. 6.8.1 Torrent Pharmaceuticals Company Information
  45. 6.8.2 Torrent Pharmaceuticals Business Overview
  46. 6.8.3 Torrent Pharmaceuticals Valsartan Drug Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Torrent Pharmaceuticals Valsartan Drug Product Portfolio
  48. 6.8.5 Torrent Pharmaceuticals Recent Developments
  49. 6.9 Square Pharmaceuticals
  50. 6.9.1 Square Pharmaceuticals Company Information
  51. 6.9.2 Square Pharmaceuticals Business Overview
  52. 6.9.3 Square Pharmaceuticals Valsartan Drug Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Square Pharmaceuticals Valsartan Drug Product Portfolio
  54. 6.9.5 Square Pharmaceuticals Recent Developments
  55. 6.10 Macleods Pharmaceuticals
  56. 6.10.1 Macleods Pharmaceuticals Company Information
  57. 6.10.2 Macleods Pharmaceuticals Business Overview
  58. 6.10.3 Macleods Pharmaceuticals Valsartan Drug Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Macleods Pharmaceuticals Valsartan Drug Product Portfolio
  60. 6.10.5 Macleods Pharmaceuticals Recent Developments
  61. 6.11 Lupin
  62. 6.11.1 Lupin Company Information
  63. 6.11.2 Lupin Business Overview
  64. 6.11.3 Lupin Valsartan Drug Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Lupin Valsartan Drug Product Portfolio
  66. 6.11.5 Lupin Recent Developments
  67. 6.12 Jubilant Pharma
  68. 6.12.1 Jubilant Pharma Company Information
  69. 6.12.2 Jubilant Pharma Business Overview
  70. 6.12.3 Jubilant Pharma Valsartan Drug Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Jubilant Pharma Valsartan Drug Product Portfolio
  72. 6.12.5 Jubilant Pharma Recent Developments
  73. 6.13 HETERO
  74. 6.13.1 HETERO Company Information
  75. 6.13.2 HETERO Business Overview
  76. 6.13.3 HETERO Valsartan Drug Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 HETERO Valsartan Drug Product Portfolio
  78. 6.13.5 HETERO Recent Developments
  79. 6.14 Aurobindo Pharma
  80. 6.14.1 Aurobindo Pharma Company Information
  81. 6.14.2 Aurobindo Pharma Business Overview
  82. 6.14.3 Aurobindo Pharma Valsartan Drug Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Aurobindo Pharma Valsartan Drug Product Portfolio
  84. 6.14.5 Aurobindo Pharma Recent Developments
  85. 6.15 Amneal Pharmaceuticals
  86. 6.15.1 Amneal Pharmaceuticals Company Information
  87. 6.15.2 Amneal Pharmaceuticals Business Overview
  88. 6.15.3 Amneal Pharmaceuticals Valsartan Drug Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Amneal Pharmaceuticals Valsartan Drug Product Portfolio
  90. 6.15.5 Amneal Pharmaceuticals Recent Developments
  91. 6.16 Alembic Pharmaceuticals
  92. 6.16.1 Alembic Pharmaceuticals Company Information
  93. 6.16.2 Alembic Pharmaceuticals Business Overview
  94. 6.16.3 Alembic Pharmaceuticals Valsartan Drug Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Alembic Pharmaceuticals Valsartan Drug Product Portfolio
  96. 6.16.5 Alembic Pharmaceuticals Recent Developments
7 North America by Country
  1. 7.1 North America Valsartan Drug Sales by Country
  2. 7.1.1 North America Valsartan Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Valsartan Drug Sales by Country (2021-2026)
  4. 7.1.3 North America Valsartan Drug Sales Forecast by Country (2027-2032)
  5. 7.2 North America Valsartan Drug Market Size by Country
  6. 7.2.1 North America Valsartan Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Valsartan Drug Market Size by Country (2021-2026)
  8. 7.2.3 North America Valsartan Drug Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Valsartan Drug Sales by Country
  2. 8.1.1 Europe Valsartan Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Valsartan Drug Sales by Country (2021-2026)
  4. 8.1.3 Europe Valsartan Drug Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Valsartan Drug Market Size by Country
  6. 8.2.1 Europe Valsartan Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Valsartan Drug Market Size by Country (2021-2026)
  8. 8.2.3 Europe Valsartan Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Valsartan Drug Sales by Country
  2. 9.1.1 Asia-Pacific Valsartan Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Valsartan Drug Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Valsartan Drug Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Valsartan Drug Market Size by Country
  6. 9.2.1 Asia-Pacific Valsartan Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Valsartan Drug Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Valsartan Drug Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Valsartan Drug Sales by Country
  2. 10.1.1 South America Valsartan Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Valsartan Drug Sales by Country (2021-2026)
  4. 10.1.3 South America Valsartan Drug Sales Forecast by Country (2027-2032)
  5. 10.2 South America Valsartan Drug Market Size by Country
  6. 10.2.1 South America Valsartan Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Valsartan Drug Market Size by Country (2021-2026)
  8. 10.2.3 South America Valsartan Drug Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Valsartan Drug Sales by Country
  2. 11.1.1 Middle East and Africa Valsartan Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Valsartan Drug Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Valsartan Drug Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Valsartan Drug Market Size by Country
  6. 11.2.1 Middle East and Africa Valsartan Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Valsartan Drug Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Valsartan Drug Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Valsartan Drug Value Chain Analysis
  2. 12.1.1 Valsartan Drug Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Valsartan Drug Production Mode & Process
  7. 12.2 Valsartan Drug Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Valsartan Drug Distributors
  10. 12.2.3 Valsartan Drug Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst